Skip to results
Modify your search
NARROW
1-20 of 24
Authors: Ambrogio Orlando
Journal Article
The Effectiveness of Risankizumab as Induction Therapy for Crohn’s Disease: Data From the Sicilian Network for Inflammatory Bowel Diseases Get access
Inflammatory Bowel Diseases, Volume 31, Issue 4, April 2025, Pages 1178–1181, https://doi.org/10.1093/ibd/izae248
Published: 26 October 2024
Journal Article
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study Free
Inflammatory Bowel Diseases, Volume 30, Issue 5, May 2024, Pages 854–858, https://doi.org/10.1093/ibd/izad118
Published: 30 June 2023
Journal Article
Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19 Free
Inflammatory Bowel Diseases, Volume 29, Issue 2, February 2023, Pages 217–221, https://doi.org/10.1093/ibd/izac064
Published: 06 April 2022
Journal Article
Prevalence, Pathogenesis and Management of Anemia in Inflammatory Bowel Disease: An IG-IBD Multicenter, Prospective, and Observational Study Free
Inflammatory Bowel Diseases, Volume 29, Issue 1, January 2023, Pages 76–84, https://doi.org/10.1093/ibd/izac054
Published: 02 April 2022
Journal Article
COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association Free
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 474–478, https://doi.org/10.1093/ibd/izab172
Published: 14 July 2021
Journal Article
Pyoderma Gangrenosum in An Ulcerative Colitis Pediatric Patient During Vedolizumab Therapy Successfully Treated With Oral Cyclosporine Free
Inflammatory Bowel Diseases, Volume 27, Issue 9, September 2021, Pages e110–e111, https://doi.org/10.1093/ibd/izab106
Published: 18 May 2021
Journal Article
BLOOD-BASED PROGNOSTIC BIOMARKERS IN CROHN’S PATIENTS TREATED WITH BIOLOGICS: A NEW PROMISING TOOL TO PREDICT ENDOSCOPIC OUTCOMES Free
Inflammatory Bowel Diseases, Volume 27, Issue Supplement_1, January 2021, Page S58, https://doi.org/10.1093/ibd/izaa347.138
Published: 21 January 2021
Journal Article
SPOSAB ABP 501 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501 Free
Inflammatory Bowel Diseases, Volume 27, Issue Supplement_1, January 2021, Page S59, https://doi.org/10.1093/ibd/izaa347.141
Published: 21 January 2021
Journal Article
Herpes Zoster Eruption During Vedolizumab Therapy: A Simple Coincidence or More? Get access
Inflammatory Bowel Diseases, Volume 26, Issue 6, June 2020, Pages e51–e52, https://doi.org/10.1093/ibd/izaa066
Published: 31 March 2020
Journal Article
The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches Get access
Inflammatory Bowel Diseases, Volume 27, Issue 2, February 2021, Pages 182–189, https://doi.org/10.1093/ibd/izaa036
Published: 21 February 2020
Journal Article
Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case–Control IG-IBD Study Get access
Inflammatory Bowel Diseases, Volume 26, Issue 3, March 2020, Pages 450–459, https://doi.org/10.1093/ibd/izz155
Published: 19 July 2019
Journal Article
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab Get access
Inflammatory Bowel Diseases, Volume 25, Issue 11, November 2019, Pages 1805–1812, https://doi.org/10.1093/ibd/izz057
Published: 01 April 2019
Journal Article
Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-Analysis Get access
Inflammatory Bowel Diseases, Volume 25, Issue 6, June 2019, Pages 987–997, https://doi.org/10.1093/ibd/izy365
Published: 22 December 2018
Journal Article
The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy Get access
Inflammatory Bowel Diseases, Volume 25, Issue 3, March 2019, Pages 568–579, https://doi.org/10.1093/ibd/izy264
Published: 18 August 2018
Journal Article
The Addition of an Immunosuppressant After Loss of Response to Anti-TNFα Monotherapy in Inflammatory Bowel Disease: A 2-Year Study Get access
Inflammatory Bowel Diseases, Volume 24, Issue 2, February 2018, Pages 394–401, https://doi.org/10.1093/ibd/izx010
Published: 18 January 2018
Journal Article
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar Get access
Inflammatory Bowel Diseases, Volume 23, Issue 2, 1 February 2017, Pages 233–243, https://doi.org/10.1097/MIB.0000000000000995
Published: 13 January 2017
Journal Article
Multifocal Pyoderma Gangrenosum Resistant to Infliximab in Active Ulcerative Colitis: Don't Forget the Role of Cyclosporin Get access
Inflammatory Bowel Diseases, Volume 18, Issue 8, 1 August 2012, Pages E1594–E1595, https://doi.org/10.1002/ibd.21915
Published: 29 October 2011
Journal Article
Adalimumab in Steroid-dependent Crohn's Disease Patients: Prognostic Factors for Clinical Benefit Get access
Inflammatory Bowel Diseases, Volume 18, Issue 5, 1 May 2012, Pages 826–831, https://doi.org/10.1002/ibd.21835
Published: 11 August 2011
Journal Article
Early postoperative recurrence of severe crohn's disease, with colonic involvement and associated human cytomegalovirus infection, treated with oral valganciclovir and adalimumab Get access
Inflammatory Bowel Diseases, Volume 17, Issue 6, 1 June 2011, Pages E43–E44, https://doi.org/10.1002/ibd.21685
Published: 21 March 2011
Journal Article
Cancer in Crohn's Disease patients treated with infliximab: A long-term multicenter matched pair study Get access
Inflammatory Bowel Diseases, Volume 17, Issue 3, 1 March 2011, Pages 758–766, https://doi.org/10.1002/ibd.21416
Published: 03 August 2010
